Virulence and disease - PowerPoint PPT Presentation

About This Presentation
Title:

Virulence and disease

Description:

Virulence and disease. What can evolution tell us about disease and ... American Jr of Ostetrics and Gynecology 186: S190-S197. Stearns, S. and Ebert, D. 2001. ... – PowerPoint PPT presentation

Number of Views:120
Avg rating:3.0/5.0
Slides: 46
Provided by: ericb8
Category:

less

Transcript and Presenter's Notes

Title: Virulence and disease


1
Virulence and disease
  • What can evolution tell us about disease and
    medicine?

2
Outline virulence and disease
  • Pathogen evolution
  • Origins of novel pathogens
  • Causes of virulence (esp. trade-off)
  • Evolution of antibiotic resistance
  • Evolution and human health
  • Disorders due to changes in environment
  • Diseases as defenses
  • Disorders due to sexual conflict

3
I. Pathogen evolution eluding the immune
system - influenza
Do amino acid substitutions occur at antigenic
sites? Sample flu lineages from 1968 to 1987.
Surviving Extinct Antigenic
sites 33 31 Non-antigenic sites 10 35
Hemagglutinin (HA) cell entry
Neuroaminidase (NA) cell exit
4
Evolution of antigenic sites
What kind of substitution in hemagglutinin? 18
codons with excess replacement (dN gt dS)
Figure 13.4
5
IB Origins of novel pathogens - influenza
  • Three types of influenza viruses
  • A and B have 8 RNA strands, C has 7
  • type A and B encode HA and NA, C does not
  • A and B can be severe, C generally mild
  • Hosts
  • type A humans, swine, horses, waterfowl, gulls
  • type B humans and seals
  • type C humans and swine
  • Flu A viruses are classified by HA type (1-15)
    and NA type (1-9)
  • only H1, H2, H3 and N1, N2 in humans (until
    recently)

6
Flu pandemics
  • 1918 Spanish flu (40m deaths) H1N1
  • 1957 Asian (1m deaths) H2N2
  • 1968 Hong Kong H3N2
  • 1977 Russian H1N1
  • 1997 Avian (22 deaths) H5N1

7
Where do pandemics come from?
Phylogeny of nucleoprotein gene of influenza A.
8
A role for pigs?
Sialic acid galactose on epithelial cell
surface key to infection binding site for
hemagglutinin (HA) Can bind two different ways.
Avian 2-3. Human 2-6.
9
H3 1968 from birds
Phylogeny of flu A hemagglutinin genes
10
IC. What causes virulence?
Virulence tendency to reduce survival or
reproductive capacity of host
11
Why doesnt HIV evolve to become more virulent?
With high virulence you get
many virions/ml blood
rapid illness and death of host
12
Evolution of Virulence Australias plague of
rabbits
13 wild introduced in 1858. 9 years later, 50 km
spread. 1870s 150 km / yr
13
Myxoma virus
14
Effect of myxoma virus on rabbits 1951-1953
15
Virulence of field strains
Class Survival time Fatality rate Year I lt13 99 II 13-16 95-99 III 17-28 70-95 IV 29-50 50-70 V - lt50
1950-1 99
1951-2 33 50 17 0 0
1952-3 4 13 74 9 0
1953-4 16 25 50 9 0
1954-5 16 16 42 26 0
Tests carried out on domestic rabbits
16
Trade-off hypothesis of virulence
17
Rabbit resistance evolves
18
What is the optimal level of virulence?
But why is there a different balance in different
pathogens--why are some more virulent than
others? Why dont some pathogens seem to become
less virulent?
19
What is the optimal level of virulence?
Water-borne diseases
20
What is the optimal level of virulence?
Vector-borne diseases
21
Second virulence hypothesis short-sighted
evolution
22
Third virulence hypothesis coincidental
23
I-D. Evolution of antibiotic resistance
  • 70 of bacterial infections requiring
    hospitalization are resistant to some antibiotic
  • Sepsis (infected blood / tissue) rates tripled in
    US from 1979 to 2000

24
Acquisition of anti-biotic resistance?
  • Time to resistance?
  • Drug Introduction Resistance
  • Penicillin 1943 1946
  • Streptomycin 1945 1959
  • Tetracycline 1948 1953
  • Vancomycin 1956 1988
  • Methicillin 1960 1961
  • Cefataxime 1985 1988

25
Modes of resistance
  • Drug action resistance
  • Tetracycline blocks translation ribosome
    mutation
  • cellular pumps upregulated
  • Penicillin blocks cell walls beta-lactamase
    digests
  • drug
  • cipro DNA packing mutation to enzymes
  • (fluoroquinolones) (inhibits
  • topoisomerase)

26
Efflux pumps
27
Experimental test of cost of resistance Schrag
(1997)
28
Initial competition without antibiotics
Time (generations)
29
After many generations in the lab?
30
After many generations in the lab?
31
An evolutionary mystery vancomycin resistance
  • Vancomycin 32 years before resistance seen.
  • 500K staph infections per year in hospitals. By
    1990s, commonly resistant to other antibiotics.
  • Until recently, the last-resort antibiotic when
    other resistant.
  • Mechanism blocks cell-wall biosynthesis by
    forming complex with peptidoglycans
  • Cross-linker D-alanine D-alanine di-peptide
  • Gram-positive bacteria

32
Mechanism of resistance
33
Vancomycin resistance
34
Origins of vancomycin resistance comparison of
amino acid sequences
Numbers above sequence similarity to VanA from
E. foecium. Below GC.
35
Source of resistance
36
Antibiotic resistance summary
37
Hypotheses to explain human disorders
  • Always deleterious
  • Sometimes deleterious
  • Only seem deleterious, actually a defense

38
G x E Myopia (near-sightedness)
Hypothesis myopia is environment dependent
Test Barrow, Alaska
Test in 1970 (35 years later) Age Myopic Not
myopic 6-35 146 202 42 35 8 152 5
39
II. Diseases are really defenses Morning
sickness
  • nausea and vomiting of pregnancy, or NVP
  • About 2/3 of all pregnant women worldwide
    affected
  • All hours (not just morning)
  • Affects healthy mothers, who have healthy babies
  • seems negative
  • reduced food intake, reduced activity level
  • why persistent and common?

40
Diseases are really defenses Morning sickness
Prediction 1 NVP most severe when need for
protection greatest
Sherman and Flaxman 2002
41
Diseases are really defenses Morning sickness
Prediction 2 NVP should be associated with
positive pregnancy outcomes
Sherman and Flaxman 2002
42
Evolution of menopause
  • 7 million oogonia at fifth fetal month
  • 2 million oocytes at birth meiotic prophase
  • 400,000 at puberty
  • 400 lost to ovulation
  • remainder degenerate (atresia) why?
  • when few remain, menopause
  • Hypotheses
  • proximate mitochondrial damage leads to
    apoptosis (but why arent there more to start
    with?)
  • adaptive??

43
Study questions
  1. If you compare the pattern of mutations in a
    virus over time, what would indicate neutral
    evolution? What would indicate that selection
    was at work?
  2. The hypothesis is that the 1918 flu virus
    incorporated many avian flu elements. Two
    hypotheses could be formulated the 1918 flu
    involved recombination between human and avian
    flu strains, or the 1918 flu involved an avian
    strain shifting to humans. Imagine that you had
    access to flu sequences from 1900, 1905, 1910,
    and 1918 for ducks and humans and that you built
    two phylogenies, one for nucleoprotein and one
    for hemagglutinin. Sketch what the phylogenies
    would need to look like to support each
    hypothesis.
  3. Explain why virulence rapidly declined for
    myxomatosis in Australian rabbits using the
    requirements of natural selection.
  4. The 1918-1920 flu epidemic killed 40 million
    people. Formulate three hypotheses for why this
    virus did not continue killing humans at such
    high rates.

44
Study questions
  • Why do some pathogens evolve to become less
    virulent but not others? Explain why some of the
    key variables include mode of transmission and
    primary hosts.
  • Consider two diseases. In one case, hosts are
    infected by a single strain at a time. In the
    other case, hosts are infected by multiple
    strains at one time. How would you predict this
    difference to affect the evolution of virulence?
  • You are investigating the hypothesis that
    antibiotic resistance in a bacterial infection
    originated via horizontal gene transfer. Explain
    how you would use phylogenies to assess this.

45
References
  • Frank, Steven A. 2002. Immunology and evolution
    of infectious disease. Princeton University
    Press.
  • Guardabassi, L. et al. 2005. Glycopeptide VanA
    Operons in Paenobacillus strains isolated from
    soil. Antimicrobrial agents and chemotherapy
    494227-4233.
  • Hay, A. J. et al. 2001. The evolution of human
    influenza viruses. Philosophical transactions of
    the Royal Society Series B 3561861-1870.
  • Hurtado, A. M. et al. 1999. The evolution
    ecology of childhood asthma. In Trevathan, W. R.
    et al., eds. Evolutionary medicine. Oxford
    University Press.
  • Launay, A. et al. 2006. Transfer of vancomycin
    resistance transposon Tn1549 from Clostridium
    symbiosum to Enterococcus spp. in the gut in
    gnotobiotic mice. Antimicrobial agents and
    chemotherapy 501054-1062.
  • Lewis, D. 2006. Avian flu to human influenza.
    Annual review of medicine 57139-154.
  • Nesse, R. M. and Williams, G. C. 1996. Why we
    get sick the new science of Darwinian medicine.
    Random House, New York.
  • Sherman and Flaxman. 2002. Nausea and vomiting
    of pregnancy in an evolutionary perspective.
    American Jr of Ostetrics and Gynecology 186
    S190-S197.
  • Stearns, S. and Ebert, D. 2001. Evolution in
    health and disease a work in progress.
    Quarterly review of biology 76417-432.
  • Walsh, C. T. et al. 1996. Bacterial resistance
    to vancomycin five genes and one missing
    hydrogen bond tell the story. Current biology
    321-28.
  • White, D. G. et al., eds. 2005. Frontiers in
    Antimicrobial Resitance. American Society for
    Microbiology.
Write a Comment
User Comments (0)
About PowerShow.com